Apyx Medical Corporation (APYX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 54.8M | 58.47M | 48.79M | 49.91M | 51.85M | 56.44M | 52.16M | 56.67M | 61.93M | 70.36M | 50.15M | 52.88M |
| Cash & Short-Term Investments | 31.14M | 31.74M | 25.14M | 29.3M | 31.01M | 31.74M | 28.01M | 32.68M | 37.28M | 43.65M | 22.13M | 18.48M |
| Cash Only | 31.14M | 31.74M | 25.14M | 29.3M | 31.01M | 31.74M | 28.01M | 32.68M | 37.28M | 43.65M | 22.13M | 18.48M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 12.76M | 16.78M | 12.99M | 11.25M | 11.64M | 15.48M | 13.04M | 12.71M | 12.49M | 14.02M | 13.24M | 20.14M |
| Days Sales Outstanding | 106.4 | 71.46 | 86.6 | 91.59 | 129.44 | 92.23 | 103.1 | 94.36 | 117.75 | 85.55 | 128.22 | 128.34 |
| Inventory | 9.54M | 8.6M | 9.14M | 8.19M | 7.68M | 7.56M | 9M | 9.32M | 9.79M | 9.92M | 11.29M | 11.17M |
| Days Inventory Outstanding | 104.4 | 38.55 | 174.13 | 168.39 | 182.26 | 144.91 | 185.95 | 93.16 | 208.89 | 92.03 | 258.33 | 234.53 |
| Other Current Assets | 1.37M | 1.35M | 1.51M | 1.17M | 1.51M | 1.66M | 2.11M | 1.96M | 2.36M | 2.76M | 3.49M | 3.1M |
| Total Non-Current Assets | 8.23M | 8.37M | 8.58M | 8.27M | 8.31M | 8.4M | 8.56M | 8.72M | 8.79M | 8.88M | 9.3M | 9.54M |
| Property, Plant & Equipment | 6.33M | 6.62M | 6.76M | 6.55M | 6.54M | 6.74M | 6.78M | 6.91M | 6.89M | 7.15M | 7.44M | 7.64M |
| Fixed Asset Turnover | 1.93x | 2.86x | 1.93x | 1.74x | 1.42x | 2.10x | 1.68x | 1.76x | 1.46x | 2.01x | 1.59x | 2.59x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.9M | 1.75M | 1.81M | 1.72M | 1.77M | 1.66M | 1.78M | 1.81M | 1.89M | 1.73M | 1.85M | 1.91M |
| Total Assets | 63.02M | 66.84M | 57.37M | 58.19M | 60.16M | 64.84M | 60.72M | 65.39M | 70.71M | 79.24M | 59.45M | 62.43M |
| Asset Turnover | 0.19x | 0.31x | 0.22x | 0.19x | 0.15x | 0.23x | 0.18x | 0.18x | 0.14x | 0.21x | 0.20x | 0.23x |
| Asset Growth % | 4.76% | 3.08% | -5.53% | -11.02% | -14.92% | -18.17% | 2.14% | 4.75% | 24.53% | 53.05% | 7.56% | 4.97% |
| Total Current Liabilities | 9.45M | 11.7M | 10.98M | 10.57M | 9.51M | 10.72M | 9.55M | 10.64M | 10.56M | 12.74M | 10.29M | 19.03M |
| Accounts Payable | 2.63M | 3.06M | 3.22M | 2.89M | 2.31M | 2.62M | 1.91M | 2.35M | 2.1M | 2.71M | 2.05M | 2.66M |
| Days Payables Outstanding | 32.73 | 13.64 | 61.4 | 55.13 | 58.8 | 39.62 | 43.25 | 21.69 | 51.01 | 20.67 | 54.17 | 48.4 |
| Short-Term Debt | 441K | 428K | 414K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.89M |
| Deferred Revenue (Current) | 714K | 0 | 1.17M | 1.48M | 430K | 693K | 499K | 778K | 515K | 488K | 712K | 442K |
| Other Current Liabilities | 3.84M | 8.21M | 4.21M | 0 | 0 | 5.08M | 0 | 4.56M | 593K | 1.54M | 1.19M | 3.78M |
| Current Ratio | 5.80x | 5.00x | 4.44x | 4.72x | 5.45x | 5.26x | 5.46x | 5.33x | 5.87x | 5.52x | 4.87x | 2.78x |
| Quick Ratio | 4.79x | 4.26x | 3.61x | 3.95x | 4.64x | 4.56x | 4.52x | 4.45x | 4.94x | 4.74x | 3.78x | 2.19x |
| Cash Conversion Cycle | 178.06 | 96.37 | 199.33 | 204.85 | 252.89 | 197.52 | 245.79 | 165.83 | 275.63 | 156.92 | 332.38 | 314.48 |
| Total Non-Current Liabilities | 40.49M | 40.31M | 40.31M | 40.17M | 40.01M | 39.79M | 39.97M | 39.83M | 39.7M | 39.58M | 15.57M | 6.67M |
| Long-Term Debt | 35.09M | 34.85M | 34.61M | 34.37M | 34.13M | 33.89M | 33.85M | 33.63M | 33.41M | 33.19M | 9.01M | 0 |
| Capital Lease Obligations | 3.93M | 4.06M | 4.19M | 4.32M | 4.42M | 4.52M | 4.64M | 4.74M | 4.84M | 4.95M | 5.05M | 5.16M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 339K | 347K | 293K | 292K | 270K | 259K | 201K | 192K | 194K | 198K | 181K | 185K |
| Total Liabilities | 49.94M | 52.01M | 51.28M | 50.73M | 49.52M | 50.51M | 49.52M | 50.47M | 50.25M | 52.32M | 25.86M | 25.7M |
| Total Debt | 39.46M | 39.34M | 39.21M | 39.08M | 38.92M | 38.76M | 38.85M | 38.7M | 38.63M | 38.5M | 14.39M | 14.41M |
| Net Debt | 8.32M | 7.6M | 14.08M | 9.78M | 7.91M | 7.02M | 10.83M | 6.02M | 1.34M | -5.15M | -7.75M | -4.07M |
| Debt / Equity | 3.02x | 2.65x | 6.45x | 5.24x | 3.66x | 2.70x | 3.47x | 2.59x | 1.89x | 1.43x | 0.43x | 0.39x |
| Debt / EBITDA | - | 169.57x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | 32.76x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -0.67x | 0.01x | -0.33x | -1.65x | -2.00x | -1.76x | -2.26x | -3.58x | -4.40x | -7.55x | -7.54x | -0.76x |
| Total Equity | 13.09M | 14.83M | 6.08M | 7.46M | 10.64M | 14.34M | 11.2M | 14.92M | 20.46M | 26.92M | 33.59M | 36.73M |
| Equity Growth % | 22.96% | 3.46% | -45.7% | -50.04% | -47.98% | -46.75% | -66.66% | -59.37% | -43.5% | -28.76% | -20.44% | -20.43% |
| Book Value per Share | 0.31 | 0.35 | 0.15 | 0.18 | 0.30 | 0.38 | 0.32 | 0.43 | 0.59 | 0.78 | 0.97 | 1.06 |
| Total Shareholders' Equity | 12.83M | 14.54M | 5.85M | 7.25M | 10.51M | 14.21M | 11.04M | 14.75M | 20.25M | 26.7M | 33.35M | 36.6M |
| Common Stock | 42K | 42K | 38K | 38K | 38K | 38K | 35K | 35K | 35K | 35K | 35K | 35K |
| Retained Earnings | -91.23M | -89.12M | -87.82M | -85.84M | -82.06M | -77.91M | -73.28M | -68.58M | -62.02M | -54.45M | -44.84M | -40.21M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 256K | 291K | 232K | 203K | 133K | 125K | 156K | 177K | 207K | 221K | 238K | 137K |